The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...

Stool-based tests for colorectal cancer (CRC) screening show no significant difference in detecting advanced neoplasia overall, but for advanced serrated lesions specifically, the multitarget stool ...

Please provide your email address to receive an email when new articles are posted on . Among all the CRC screening methods, CRC incidence and mortality rates were highest among those who received ...

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...

In a new study aimed at identifying the best approach to promote colorectal cancer screening in adults aged 45 to 49, UCLA researchers found that simply mailing a stool-based test directly to people's ...

Mailing mt-sDNA tests to Medicare Advantage enrollees improved CRC screening adherence, with a 49.4% overall adherence rate. Digital outreach, especially combining email and text, significantly ...

Please provide your email address to receive an email when new articles are posted on . Compared with the original Cologuard test approved by the FDA in 2014, the company’s next-generation test uses ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

Colonoscopies are considered the gold standard for detecting colorectal cancer. But some dread the idea of the invasive procedure and the prep required the day before you have it. The FDA last year ...

Each year, close to 2 million people around the world are diagnosed with colorectal cancer and roughly 935,000 people die from it. Scientists say they have developed a new stool test that is more ...